SEC Form D filing

Clover Biopharmaceuticals, Ltd., 2026-04-29

An SEC Form D private-offering notice from Chengdu, a $3,642,978 filer-stated offering target in Biotech. Filed 2026-04-29. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Clover Biopharmaceuticals, Ltd. site↗ Verified via SEC Form D

Clinical stage biotechnology company developing vaccines, including COVID 19 and RSV candidates, built on its Trimer Tag protein technology platform

Filed 2026-04-29Filed to raise $3,642,978First money in 2026-03-27Raised so far $3,642,978HQ (as filed) ChengduSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified cloverbiopharma.com↗Named in the filing 3 executives & directors
Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source